KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $2.2 billion.

  • Eli Lilly's Other Working Capital Changes rose 118150.97% to $2.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.6 billion, marking a year-over-year increase of 9840.89%. This contributed to the annual value of $6.6 billion for FY2025, which is 9840.89% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Other Working Capital Changes is $2.2 billion, which was up 118150.97% from -$1.2 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Other Working Capital Changes registered a high of $3.6 billion during Q4 2023, and its lowest value of -$2.1 billion during Q4 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was $179.7 million (2021), whereas its average is $633.6 million.
  • Examining YoY changes over the last 5 years, Eli Lilly's Other Working Capital Changes showed a top increase of 118150.97% in 2025 and a maximum decrease of 1242857.14% in 2025.
  • Eli Lilly's Other Working Capital Changes (Quarter) stood at -$2.1 billion in 2021, then surged by 178.36% to $1.6 billion in 2022, then skyrocketed by 120.81% to $3.6 billion in 2023, then crashed by 95.21% to $170.9 million in 2024, then skyrocketed by 1181.51% to $2.2 billion in 2025.
  • Its Other Working Capital Changes stands at $2.2 billion for Q4 2025, versus -$1.2 billion for Q3 2025 and $2.3 billion for Q2 2025.